T 0990/91 of 25.05.1992
- European Case Law Identifier
- ECLI:EP:BA:1992:T099091.19920525
- Date of decision
- 25 May 1992
- Case number
- T 0990/91
- Petition for review of
- -
- Application number
- 89308480.6
- IPC class
- C07D 417/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Hemiphosphate hemihydrate of 2-(1-pentyl-3-guanidino-4- imidazolyl)thiazole
- Applicant name
- Pfizer Inc.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(1) 1973European Patent Convention R 67 1973European Patent Convention R 88 1973
- Keywords
- Correction of chemical name (allowed)
Substantial procedural violation (no) - reimbursement of appeal fee (no) - Catchword
- -
- Cited cases
- -
ORDER
For these reasons, it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the Examining Division for further prosecution on the basis that the compound name 2-(1- pentyl-3-guanidino-4-imidazolyl)thiazole is amended to read 2-(1-pentyl-3-guanidino)-4-(2-methyl-4- imidazolyl)thiazole wherever it occurs.
3. Reimbursement of the appeal fee is refused.